Gateway 2012: Cambridge Major Laboratories
CAMBRIDGE MAJOR LABORATORIES – CRYSTALLIZATION AND SOLID STATE CHEMISTRY SERVICES
Cambridge Major Laboratories (CML) has established a new Center of Excellence for Crystallization and Solid State Chemistry in our Active Pharmaceutical Ingredient (API) development facilities in the Netherlands. Significant investments have been made in equipment and personnel as part of CML’s expansion into solid state services.
CML'S Solid State Chemistry Services
- Crystallization Study – crystallize to obtain stable solids, for purification or isolation
- Material Characterization – polymorph identification
- Solubility Determination – in production solvents and buffer solutions
- Salt Selection – suitable form selection
- Polymorph Study – behavior in production solvents
- Crystallization Process Development – combine optimal synthesis conditions with optimal crystallization conditions
- Crystal Habit Optimization – control of particle size and shape
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
